Crinetics Pharmaceuticals (CRNX) Stock Highlights

56.07 | +1.63%

2024-11-21 01:38:08

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidates include paltusotine which is in clinical development for the treatment of acromegaly and neuroendocrine tumors, or NETs, CRN04777, which is in clinical development for congenital hyperinsulinism, or HI, and CRN04894, which is in clinical development for diseases of excess adrenocorticotrophic hormone, or ACTH, including Cushings Disease, congenital adrenal hyperplasia, or CAH, and Ectopic ACTH Syndrome, or EAS.

Statistics

Range Today

54.64 56.43

Volume Today 463.93K

Range 1 Year

29.23 62.53

Volume 1 Year 202.31M

Range 3 Year

15.23 62.53

Volume 3 Year 457.04M

Range 10 Year

10.63 62.53

Volume 10 Year 564.91M

Highlights

Market Capitalization 5.46B (mid)

Floating Shares 78.9M

Current Price 56.07

Price To Earnings -15.85

Price To Revenue 2.87K

Price To Book 5.79

Earnings Per Share -3.76

Payout Ratio 0%

Performance

Latest +1.63%

1 Month -4.33%

3 Months +6.19%

6 Months +9.06%

1 Year +86.53%

3 Years +103.67%

5 Years +205.73%

10 Years +191.27%

Benchmarks

Market Capitalization

66 / 368

Gross Profits

245 / 278

Total Revenue

201 / 300

Total Rank

95 / 368

Free Cashflow

281 / 352

Performance 5 years

42 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.